Similarly, though many different SEC23B mutations have been identified in patients with CDAII, no patients have yet been identified who are homozygous or compound heterozygous for 2 null mutations, suggesting that complete SEC23B deficiency might also result in early lethality. Here, SEC23B is linked to Congenital dyserythropoietic anemia type II.